ホーム
探索
nav.journalClub
トレンド
その他
synapse
⌘+K
言語
日本語
日本語
May 11, 2026
Open Access
Sodium-glucose Co-transporter 2 (SGLT2) inhibitor dapagliflozin acutely activates cardiomyocyte HIF-1α signaling via succinate, a signaling metabolite
TS
Tatsuyuki Sato
Jichi Medical University
TI
Takayuki Isagawa
Jichi Medical University
YS
Yuki Sugiura
See all
Key Points
Key points are not available for this paper at this time.
Read Full Paper
externally
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Sodium-glucose Co-transporter 2 (SGLT2) inhibitor dapagliflozin acutely activates cardiomyocyte HIF-1α signaling via succinate, a signaling metabolite | Synapse
Cite This Study
Copy
Sato et al. (Wed,) studied this question.
synapsesocial.com/papers/6a025f2bc9581ed855361d19
https://doi.org/https://doi.org/10.5167/uzh-433967